Research priorities in geriatric oncology: addressing the needs of an aging population
- PMID: 22308521
- PMCID: PMC3747652
- DOI: 10.6004/jnccn.2012.0025
Research priorities in geriatric oncology: addressing the needs of an aging population
References
-
- Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27:2758–2765. - PubMed
-
- Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383–1389. - PubMed
-
- Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720–2726. - PubMed
-
- Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol. 2004;22:4626–4631. - PubMed
-
- Sehl M, Sawhney R, Naeim A. Physiologic aspects of aging: impact on cancer management and decision making, part II. Cancer J. 2005;11:461–473. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
